Answer
Darunavir inhibits HIV-1 protease dimerisation and catalytic activity, selectively blocking cleavage of HIV-encoded Gag-Pol polyproteins in infected cells and thereby preventing formation of mature infectious virus particles.
Sources for this answer
- Darunavir 800 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked